CNB Financial Corporation
NASDAQ:CCNEBanks - Regional
+$0.17 today
- Market cap
- $1.02B
- Beta
- 0.64
- P/E (TTM)
- 11.6
- EPS (TTM)
- $2.77
- Dividend yield
- 2.31%
Volume 0.12M
Average 0.16M
CCNE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
CNB Financial CorporationNASDAQ: CCNE
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CCNE compares with its peers on the latest reported figures
- CCNE's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CCNE, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CCNE) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CCNE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 209.2M | 243.7M | 322.01M | 360.01M | 404.86M |
| Cost of Revenue | 25.82M | 32.67M | 109.86M | 147.22M | 159.16M |
| Gross Profit | 183.38M | 211.04M | 212.15M | 212.79M | 245.7M |
| Gross Margin | 87.7% | 86.6% | 65.9% | 59.1% | 60.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 65.77M | 77.14M | 78.07M | 80.8M | 7.31M |
| Operating Expenses | 112.6M | 132.82M | 140.32M | 145.43M | 163.23M |
| Depreciation & Amortization | 6.24M | 6.57M | 7.74M | 8.27M | 10.91M |
| EBITDA | 77.02M | 84.79M | 79.57M | 75.63M | 93.37M |
| EBITDA Margin | 36.8% | 34.8% | 24.7% | 21.0% | 23.1% |
| Operating Income | 70.78M | 78.21M | 71.83M | 67.36M | 82.47M |
| Operating Margin | 33.8% | 32.1% | 22.3% | 18.7% | 20.4% |
| Interest Income | 179.6M | 213.58M | 293.23M | 325.1M | 392.35M |
| Interest Expense | 19.82M | 24.08M | 103.87M | 138M | 150.31M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 70.78M | 78.21M | 71.83M | 67.36M | 82.47M |
| Pre-Tax Margin | 33.8% | 32.1% | 22.3% | 18.7% | 20.4% |
| Income Tax Expense | 13.07M | 15.03M | 13.81M | 12.78M | 16.33M |
| Net Income | 57.71M | 63.19M | 58.02M | 54.58M | 66.13M |
| Net Margin | 27.6% | 25.9% | 18.0% | 15.2% | 16.3% |
| EPS (Basic) | 3.16 | 3.26 | 2.56 | 2.40 | 2.51 |
| EPS (Diluted) | 3.16 | 3.26 | 2.55 | 2.39 | 2.51 |
| Weighted Avg Shares | 16.82M | 21.01M | 20.9M | 20.84M | 24.67M |
| Weighted Avg Shares (Diluted) | 16.82M | 21.01M | 20.94M | 20.9M | 24.67M |
CNB Financial Corporation
NASDAQ:CCNE
Intrinsic Alpha fair value
Locked
Current Price
$34.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.